GL1X · GenesisL1 explorer

MolNFT v1 · #50095 · protein

Crystal structure of purp from pyrococcus furiosus complexed with ATP

2R86 · Purp protein PF1517: “Crystal structure of purp from pyrococcus furiosus complexed with ATP”. X-ray diffraction, 3 ligands (ATP, NA, PO4), 3 pockets (best druggability 0.69). MolNFT v1 #50095 on GenesisL1: 3D structure, binding…

PDB
2R86
Type
protein
Length
652 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Purp protein PF1517
UniProt
Q8U0R7
Ligands
ATP, NA, PO4
Pockets
3 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 38% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APurp protein PF1517protein33438% helix, 24% strandQ8U0R7
BPurp protein PF1517protein31838% helix, 25% strandQ8U0R7

Ligands and binding sites

  • ATP · Adenosine-5'-triphosphate · ligand · 2 copies · chains A, B
  • NA · Sodium ion · metal · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 4 copies · chains A, B
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16270.690.7764PO4, NA, ATP, MPD
24740.630.7644NA, ATP
3550.350.7917PO4

Interfaces

1 interface between chains.

  • A–B · 353 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 2R86 · Crystal structure of PurP from Pyrococcus furiosus complexed with ATP · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8U0R7 · AlphaFold monomer V2.0 prediction for 5-formaminoimidazole-4-carboxamide-1-(beta)-D-ribofu… · a predicted model of the same protein · chain B against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.